Reflow Medical on LinkedIn: Drug Delivery From ATK to BTK: What Is on the Horizon? - Endovascular Today (2024)

See you Nov. 3-6 at The VIVA Foundationconference in Las Vegas, NV! 🎰Join us Tuesday, Nov. 5 for a talk by Thomas Zeller, MD: "Retrievable Scaffold Therapy in Combination with a Paclitaxel-Coated Balloon: Two-Year Results of the DEEPER OUS Trial." It's among the Late Breaking Clinical Trials presentation moderated by Brian G. DeRubertis, MD, FACS.Also on Tuesday, Andrew Holden, 𝗠𝗗 presents "Specialty Balloons and the Future of DCB Technologies BTK."For information about our products, visit:https://lnkd.in/gtAifsaa#interventionalradiology#VI#PAD#CLIfighters#endovascular#CLTI#SpurRST

22

The latest data on tibial vessel recoil after treatment with Spur® RST is now published in the Journal of Endovascular Therapy (JEVT). The study examined the occurrence and short-term impact of acute vessel recoil in a subset of patients treated with retrievable scaffold therapy (RST) via the Spur Peripheral Retrievable Scaffold System. https://lnkd.in/dYaUkeAThe Spur is a self-expanding scaffold with an integrated dilatation balloon catheter designed for controlled penetration and lesion preparation through a series of radially expandable spikes. It creates channels that modify the lesion morphology, decreasing the recoil effect and changing vessel compliance. These channels optimize drug uptake when used with a commercially available drug-coated balloon (DCB).Read the article:https://lnkd.in/dwDsakSZ#endovascular#CLI#CLIFighters#interventionalradiology#VI#CLTI#PAD

43

Spur® RST: revolutionary BTK treatment for CLTI in conjunction with a DCB. Learn about the Spur Peripheral Retrievable Scaffold System and Retrievable Scaffold Therapy (RST). https://lnkd.in/g9gW2W4yThe Spur System is a self-expanding scaffold with an integrated dilatation balloon catheter designed for controlled penetration and lesion preparation through a series of radially expandable spikes. It creates channels that modify the lesion morphology, decreasing the recoil effect and changing vessel compliance. These channels optimize drug uptake when used with a commercially available drug-coated balloon (DCB).To learn more about clinical outcomes, we invite you to view (free) the CIRSE 2024 Satellite Symposium, "Spur RST: maximizing BTK CLTI treatment outcomes." https://shorturl.at/zSQ0kIntended Use:The Spur is intended to treat de novo or restenotic lesions in the infrapopliteal arteries to prepare the vessel for treatment with a commercially availabledrug-coated balloon to enhance drug absorption.Refer to the Instructions for Use for a complete listing of the Indications, Contraindications, Warnings, Precautions, Adverse Events, and Procedural Steps.https://lnkd.in/gCDbTi8q#CIRSESociety #interventionalradiology #VI #PAD #CLIfighters #Endovascular #CLTI #SpurRST

136

4 Comments

Stop by and say hi to Reflow's Michael Sarff, Sr. Clinical Specialist Daniel Vaillancourt and Ashlyn Burgess!

24

1 Comment

Congratulations to our own Isa R., Reflow's CEO & Co-founder! Isa was named Corporate Champion of Brand Awareness in the Global PAD IMPACT Awards by The Way To My Heart Co-founder & CEO Kym McNicholas.John Phillips, MD talks to Isa about the effort to raise awareness of PAD and the individuals and companies who support it with their actions.#PAD #interventionalradiology #peripheralarterydisease #CLTI #CLI #VI

37

1 Comment

Did you catch them all? Awesome presentations on Spur® RST at #AMPEU, the Amputation Prevention Symposium. We sincerely thank our physician colleagues! 👨⚕️ - Prof. Jos van den Berg gave updates on the DEEPER OUS trial, 2-year data. - Dr. Daniel van den Heuvel presented a "Live in a Box" session sponsored by Reflow. - Prof. Marcus Thieme discussed the "DEEPER OUS Single Center Experience: 2-year Data."Congratulations to HMP Global on hosting a great conference! 👏 More about Spur Retrievable Peripheral Scaffold Therapy: https://lnkd.in/g9gW2W4y#AMPEU #PAD #endovascular #CLI #CLIFighters #interventionalradiology #VI #CLTI

49

Congratulations to Dr. Daniel van den Heuvel and his team at St. Antonius Hospital Nieuwegein, The Netherlandson performing the first Spur® RST cases!Visiting#AMPEU, theAmputation Prevention SymposiumEurope?Join us on Tuesday, October 1 at 10.40 for the Live in a Box case presentation:"Spur RST: An Innovative Approach in Treating BTK CLTI" presented by Dr. van den Heuvel.We look forward to seeing you there!For more information, visit:https://lnkd.in/g9gW2W4y#AMPEU#PAD#endovascular#CLI#CLIFighters#interventionalradiology#VI#CLTI#SpurRST

90

1 Comment